Within Biotechnology & Pharmaceuticals industry Green Planet Bioengineering Co Ltd booked the highest Quick Ratio than Green Planet Bioengineering Co Ltd in the first quarter 2026. While total ranking remained the same in the Q1 2026 compared to the fourth quarter 2025 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents GPLB�s has?
What are GPLB�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GPLB Quick Ratio	(Mar 31 2026) Q2	(Dec 31 2025) Q1	(Sep 30 2025) Q4	(Jun 30 2025) Q3	(Mar 31 2025) Q2
Y / Y Current Liabilities Change	94.44 %	196.76 %	38.8 %	-11.98 %	53.77 %
Y / Y Cash & cash equivalent Change	-	-	-	-	-
Quick Ratio MRQ	-	-	-	-	-
GPLB's Total Ranking	#	#	#	#	#
Seq. Current Liabilities Change	-35.06 %	193.98 %	57.68 %	-35.41 %	-0.89 %
Seq. Cash & cash equivalent Change	-	-	-	-	-

Quick Ratio first quarter 2026 Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	#
Healthcare Sector	#
Overall Market	#

Quick Ratio Statistics
High	Average	Low
0	0	0

Financial Statements
Green Planet Bioengineering Co Ltd 's Current Liabilities	$ 0 Millions	Visit GPLB's Balance sheet
Green Planet Bioengineering Co Ltd 's Cash & cash equivalent	$ 0 Millions	Visit GPLB's Balance sheet
Source of GPLB's Sales		Visit GPLB's Sales by Geography

Cumulative Green Planet Bioengineering Co Ltd 's Quick Ratio

GPLB's Quick Ratio for the trailling 12 Months

GPLB Quick Ratio	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months	(Mar 31 2025) 12 Months
Y / Y Current Liabilities TTM Growth	89.93 %	80.97 %	-95.46 %	-95.81 %	-95.7 %
Y / Y Cash & cash equivalent TTM Growth	-	-	-	-	-
Quick Ratio TTM	-	-	-	-	-
Total Ranking TTM
Seq. Current Liabilities TTM Growth	16.69 %	54.05 %	8.4 %	-2.53 %	11.18 %
Seq. Cash & cash equivalent TTM Growth	-	-	-	-	-

Quick ratio ranking by company, industry and sector >> Back to GPLB Financial Strength Comparisons >> Go to Compare GPLB Quick Ratio to its Competitors

On the trailing twelve months basis
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry GPLB achieved the highest Quick Ratio. While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents GPLB�s has?
What are GPLB�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Biotechnology & Pharmaceuticals Industry	#
Healthcare Sector	#
Within the Market	#

trailing twelve months Quick Ratio Statistics
High	Average	Low
0	0	0

Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Biotechnology & Pharmaceuticals Industry

Quick Ratio

Mar 31 2026 MRQ Cash & cash equivalent

Mar 31 2026 MRQ Current Liabilities

Date modified: 2026-09-02T20:51:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.